Alnylam director receives RSUs and stock options
ALNYLAM PHARMACEUTICALS, INC. director Peter N. Kellogg reported equity awards as part of his compensation.
Rhea-AI Filing Summary
ALNYLAM PHARMACEUTICALS, INC. director Peter N. Kellogg reported equity awards as part of his compensation. He received 671 restricted stock units, each representing one share of common stock, and 1,441 stock options with an exercise price of $298.48 per share.
The RSUs and options will each vest in full on the earlier of the first anniversary of the May 20, 2026 grant date or his earlier retirement or resignation, if that occurs no more than 90 days before the first anniversary. After the RSU grant, he directly holds 1,446 common shares and 1,441 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,112 shares
Grant/Award
2 txns
Insider
KELLOGG PETER N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,441 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 671 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,441 contracts (Direct);
Common Stock — 1,446 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- F2. The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Key Figures
RSUs granted: 671 units
Options granted: 1,441 options
Option exercise price: $298.48 per share
+4 more
7 metrics
RSUs granted
671 units
Restricted stock units granted to director on May 20, 2026
Options granted
1,441 options
Stock Option (Right to Buy) granted on May 20, 2026
Option exercise price
$298.48 per share
Exercise price for 1,441 stock options
Shares held after RSU grant
1,446 shares
Total common stock directly held following RSU award
Options outstanding after grant
1,441 options
Total stock options directly held following grant
Option expiration
2036-05-20
Expiration date of granted stock options
Option vesting trigger
First anniversary or earlier qualifying departure
Vesting condition for stock options
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy), Second Amended and Restated 2018 Stock Incentive Plan, exercise price, +1 more
5 terms
restricted stock units (RSUs) financial
"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 298.4800 and expiration date in 2036."
Second Amended and Restated 2018 Stock Incentive Plan financial
"RSUs granted under the Second Amended and Restated 2018 Stock Incentive Plan."
exercise price financial
"conversion_or_exercise_price: 298.4800 for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The stock option has an expiration date of 2036-05-20."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALNY director Peter N. Kellogg report?
Peter N. Kellogg reported receiving equity awards from Alnylam. He was granted 671 restricted stock units and 1,441 stock options as compensation, rather than buying shares on the open market, according to the Form 4 disclosure.
How many Alnylam (ALNY) RSUs did Peter Kellogg receive in this filing?
Peter Kellogg received 671 restricted stock units (RSUs). Each RSU represents a contingent right to one Alnylam common share, subject to vesting conditions tied to time and potential retirement or resignation as described in the award terms.
What are the terms of Peter Kellogg’s new Alnylam stock options?
Kellogg was granted 1,441 stock options with an exercise price of $298.48 per share. The options vest in full on the earlier of the first anniversary of the grant date or qualifying retirement or resignation, and expire in 2036.
When do Peter Kellogg’s Alnylam RSUs vest?
The 671 RSUs will vest in full on the earlier of the first anniversary of the grant date or the date of any earlier retirement or resignation, provided that retirement or resignation occurs no more than 90 days before that first anniversary.
Under which plan were Peter Kellogg’s Alnylam equity awards granted?
The RSUs were granted under Alnylam’s Second Amended and Restated 2018 Stock Incentive Plan. This plan is used to provide equity-based compensation, aligning directors’ interests with shareholders through stock and option awards subject to vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
